RB
Roy D. Baynes (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.8M of NTRA (12,780 sh across 8 lots, as filed), executed Nov 19 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.5M
shares × price, as filed
Last traded
Jun 12
Filed Jun 16
Median ADV $454.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
NTRASALE
Natera, Inc.
View filing →
$5.4M37,230 sh across 6 lots
Exec Nov 15 2024
Filed Nov 15 2024 · 5:30 PM ET